Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

Author： Monami Matteo   Filippi Luca   Ungar Andrea   Sgrilli Federica   Antenore Alessandro   Dicembrini Ilaria   Bagnoli Paola   Marchionni Niccolò   Rotella Carlo Maria   Mannucci Edoardo  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.4, 2013-04, pp. : 369-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non‐selective beta‐blockers may reduce risk of hepatocellular carcinoma: a meta‐analysis of randomized trials

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 2009-2016

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Angiotensin Receptor Blockers on Flow-Mediated Vasodilation: A Meta-Analysis of Randomized Controlled Trials

By  

Cardiology, Vol. 131, Iss. 2, 2015-04 ,pp. : 69-79

Karger

Access to resources Recommend Favorite

Bisphosphonate use and the risk of endometrial cancer: a meta‐analysis of observational studies

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 25, Iss. 10, 2016-10 ,pp. : 1107-1115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3444-3451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Recursive Partitioning Analysis in Clinical Trials and Meta-Analysis of Randomized Clinical Trials, 1990-2016

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 1, 2017-01 ,pp. : 3-7

Bentham Science Publishers

Access to resources Recommend Favorite